Five things that disqualify a biotech SBIR before anyone reads your science
Most rejected SBIR applications are not rejected on the science. They are screened out on eligibility, ownership, or a registration that expired — usually weeks before a reviewer opens the file.
The painful thing about a failed SBIR application is rarely the score. It is finding out that the six weeks your CSO spent writing never reached a reviewer at all, because something structural ruled you out on receipt.
These are the five that catch early-stage biotech companies most often. None of them are about your data.
1. Ownership, once you have taken venture money
SBIR requires the applicant to be a small business concern that is more than 50% directly owned and controlled by individuals who are US citizens or permanent residents, by other eligible small businesses, or by a combination of those.
This is the one that surprises venture-backed founders. Multiple institutional investors can collectively push you past that threshold without any single one of them controlling the company. NIH and a handful of other agencies can permit majority ownership by multiple venture capital operating companies, but that runs through a separate route with its own conditions — it is not automatic, and it is not the default assumption a first-time applicant should make.
Check your cap table against the rule before you write, not after.
2. Where your principal investigator actually works
For SBIR, the PI's primary employment must be with the small business at the time of award — more than half their time, working for you.
This is where academic co-founders fail. If your scientific founder still holds a full-time faculty appointment, they usually cannot be the PI on an SBIR.
STTR exists precisely for that arrangement. It requires a formal partnership with a nonprofit research institution and a minimum split of the work between the two, and it permits the PI to sit at either organisation. If your science lives substantially in a university lab, STTR is often the correct mechanism and SBIR is the wrong one.
Picking the wrong one of these two is not a scoring penalty. It is a rejection.
3. Registrations that take weeks and expire annually
Before you can submit anything you need an active SAM.gov registration with a Unique Entity ID, a Grants.gov account, and for NIH an eRA Commons account.
Two things go wrong here:
- New registrations take weeks. Entity validation can stall on a mismatch
between your incorporation documents and what you typed. Founders routinely discover this in the final week and miss the cycle.
- SAM registration expires every year. A lapsed registration blocks
submission on deadline day, and deadline day is exactly when you will find out.
Check your expiry date now. It is the cheapest thing on this list to fix and the most humiliating one to be caught by.
4. Applying to a solicitation that was never for you
Announcements carry eligibility language that is easy to skim past: some are restricted to specific institution types, some are set aside for particular categories of small business, some require a clinical component, and some are open only to first-time applicants.
The relevant text is usually not in the summary. It is on page thirty of the full announcement, in the section nobody reads until the science is already written.
Read the eligibility section first. If it takes ten minutes and rules you out, that is the best ten minutes you will spend on the application.
5. Treating the deadline as the deadline
The posted close date is not your deadline. Your deadline is the earliest of:
- when your registrations must be active,
- when letters of support have to be back from people who do not work for you,
- when your institutional signing official is available,
- and when the submission portal stops being forgiving.
Work backwards from the posted date and the real start is usually four to six weeks earlier than founders assume. Federal programmes typically run one or two cycles a year, so missing by a day is not a delay of a day.
The pattern
Every item here is knowable before a single page is written, and every one of them is a hard stop rather than a lost point. The expensive failure in non-dilutive funding is almost never a weak application. It is a strong application that was never eligible.
That is exactly why SixthGrant checks eligibility against your company profile before it recommends anything, and why an unknown is shown as a question to confirm rather than a green tick.
None of the above is legal advice, and the agency's own eligibility section is always the authority. Rules change; the solicitation in front of you wins.
Stop finding out too late.
SixthGrant reads every federal solicitation daily, checks each one against your company, and tells you what changed.
See what it costs →